Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Acta Bio-Medica : Atenei Parmensis|August 4, 2023
Real life use of prostacyclin analog (iloprost), a multi-centric survey data from the Scleroderma study group Emilia Romagna (Sclero-RER) and review of the literatureLuca Magnani, Alarico Ariani, Andrea Lo Monaco, et al.
Clinical Rheumatology|July 7, 2022
Apremilast retention rate in clinical practice: observations from an Italian multi-center studyAlarico Ariani, Simone Parisi, Patrizia Del Medico, et al.
Mediterranean Journal of Rheumatology|January 31, 2025
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre StudyAntonella Farina, Patrizia Del Medico, Simone Parisi, et al.
Biomedicines|February 25, 2023
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric StudyAndrea Becciolini, Simone Parisi, Patrizia Del Medico, et al.
Journal of Clinical Medicine|June 28, 2023
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter StudyAlberto Lo Gullo, Andrea Becciolini, Simone Parisi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 21, 2024
Relationship Between Ultrasound and Physical Examination in the Assessment of Enthesitis in Patients With Spondyloarthritis: Results From the DEUS Multicenter StudyAndrea Di Matteo, Stefano Di Donato, Gianluca Smerilli, et al.
Annals of the Rheumatic Diseases|March 5, 2024
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre studyAndrea Di Matteo, Gianluca Smerilli, Stefano Di Donato, et al.
Seminars in Arthritis and Rheumatism|September 6, 2025
Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre studyStefano Di Donato, Gianluca Smerilli, Andrea Becciolini, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort StudyMarino Paroli, Andrea Becciolini, Elena Bravi, et al.
Minerva Medica|October 8, 2024
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritisAlberto Lo Gullo, Simone Parisi, Andrea Becciolini, et al.
Pageof 7